Cargando…
Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
SIMPLE SUMMARY: Cisplatin is a broadly used chemotherapy drug, but its use and efficacy are limited by its nephrotoxicity. Autophagy protects against kidney injury during cisplatin exposure but may reduce the efficacy of chemotherapy by protecting cancer cells. In this review, we describe the role a...
Autores principales: | Hu, Xiaoru, Ma, Zhengwei, Wen, Lu, Li, Siyao, Dong, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616020/ https://www.ncbi.nlm.nih.gov/pubmed/34830772 http://dx.doi.org/10.3390/cancers13225618 |
Ejemplares similares
-
HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential
por: Li, Siyao, et al.
Publicado: (2021) -
Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity
por: Li, Siyao, et al.
Publicado: (2023) -
p53 in Proximal Tubules Mediates Chronic Kidney Problems after Cisplatin Treatment
por: Fu, Shuangshuang, et al.
Publicado: (2022) -
Mechanisms of Cisplatin Nephrotoxicity
por: Miller, Ronald P., et al.
Publicado: (2010) -
Prevention of cisplatin nephrotoxicity
por: Hayati, Fatemeh, et al.
Publicado: (2015)